2170 Results

People

  1. Busam
    Busam
  2. Marghoob
    Marghoob
  3. Halpern
    Halpern
  4. Houghton
    Houghton
  5. Coit
    Coit
  6. Wolchok
    Wolchok
  7. Old
    Old
  8. Chapman
    Chapman
  9. Postow
    Postow
  10. Dusza
    Dusza

Groups

  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)
  7. Dermatology (393)
  8. Dermatology Service (387)
  9. Melanoma and Immunotherapeutics Service (380)
  10. Population Sciences Research Program (361)
  1. "melanoma"
Formats
  1. Journal Article (1939)
  2. Review (86)
  3. Editorial (32)
  4. Research Letter (28)
  5. Book Section (27)
  6. Conference Paper (19)
  7. Meeting Abstract (12)
  8. Guidelines (11)
  9. Miscellaneous (9)
  10. Correspondence (7)
Groups
  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)

More Groups

People
  1. Klaus Busam (217)
  2. Ashfaq Marghoob (212)
  3. Jedd Wolchok (180)
  4. Allan Halpern (153)
  5. Alan Houghton (138)
  6. Paul Chapman (125)

More People

Years
  1. 2025 (48)
  2. 2024 (94)
  3. 2023 (92)
  4. 2022 (94)
  5. 2021 (63)
  6. 2020 (76)

More Years

Publications
  1. Journal of the American Academy of Dermatology (89)
  2. Annals of Surgical Oncology (65)
  3. Journal of Clinical Oncology (65)
  4. Clinical Cancer Research (56)
  5. Cancer Research (48)
  6. Cancer (45)

More Publications

Publishers
  1. Elsevier Inc. (206)
  2. Springer (184)
  3. Wiley Blackwell (173)
  4. Lippincott Williams & Wilkins (166)
  5. American Association for Cancer Research (141)
  6. Mosby Elsevier (95)

More Publishers

Results (2170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies
    Journal Article

    Bander, E. D.; Yuan, M.; Carnevale, J. A.; Reiner, A. S.; Panageas, K. S.; Postow, M. A.; Tabar, V.; Moss, N. S.
    Cancer (2021)

    Fulltext@MSK | Save
  • Immune-related cutaneous adverse events due to checkpoint inhibitors
    Review

    Wang, E.; Kraehenbuehl, L.; Ketosugbo, K.; Kern, J. A.; Lacouture, M. E.; Leung, D. Y. M.
    Annals of Allergy, Asthma & Immunology (2021)

    Fulltext@MSK | Save
  • PRAME immunohistochemistry as an ancillary test for the assessment of melanocytic lesions
    Review

    Lezcano, C.; Jungbluth, A. A.; Busam, K. J.
    Surgical Pathology Clinics (2021)

    Fulltext@MSK | Save
  • Durable 5-year local control for resected brain metastases with early adjuvant SRS: The effect of timing on intended-field control
    Journal Article

    Bander, E. D.; Yuan, M.; Reiner, A. S.; Panageas, K. S.; Ballangrud, Å M.; Brennan, C. W.; Beal, K.; Tabar, V.; Moss, N. S.
    Neuro-Oncology Practice (2021)

    Fulltext@MSK | Save
  • Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: A multicentre, retrospective, cohort study
    Journal Article

    Pires da Silva, I.; Ahmed, T.; Reijers, I. L. M.; Weppler, A. M.; Betof Warner, A.; Patrinely, J. R.; Serra-Bellver, P.; Allayous, C.; Mangana, J.; Nguyen, K.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • EZH2 inhibition by tazemetostat: Mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma
    Review

    Julia, E.; Salles, G.
    Future Oncology (2021)

    Fulltext@MSK | Save
  • Melanoma models for the next generation of therapies
    Review

    Patton, E. E.; Mueller, K. L.; Adams, D. J.; Anandasabapathy, N.; Aplin, A. E.; Bertolotto, C.; Bosenberg, M.; Ceol, C. J.; Burd, C. E.; Chi, P.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Decreased public pursuit of cancer-related information during the COVID-19 pandemic in the United States
    Journal Article

    Adelhoefer, S.; Berning, P.; Solomon, S. B.; Maybody, M.; Whelton, S. P.; Blaha, M. J.; Dzaye, O.
    Cancer Causes & Control (2021)

    Fulltext@MSK | Save
  • Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type
    Journal Article

    Navarrete-Dechent, C.; Aleissa, S.; Connolly, K.; Hibler, B. P.; Dusza, S. W.; Rossi, A. M.; Lee, E.; Nehal, K. S.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save